Work

Data from BEAMing Sheds Light on Drug Resistance

Year: 2023

Type: other

Abstract: Targeted therapies against somatically altered genes are currently used for the treatment of many human cancers. The nascent technology known as BEAMing has the potential to increase the clinical utility of these agents because it allows for the detection of cancer mutations in peripheral blood, providing a rapid assessment of tumor mutation status. Clin Cancer Res; 17(24); 7508–10. ©2011 AACR.

DOI: 10.1158/1078-0432.c.6520604.v1

Authors: Josh Lauring, Ben Ho Park

Language: English

Topic: Cancer Genomics and Diagnostics

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361950033

Cites:

Cited by:

Related to: 10